NeuroSense Therapeutics announces annual general meeting of shareholders
NRSN•NeuroSense Therapeutics will hold its annual general meeting in Ra'anana, Israel, on December 29, 2026. Shareholders will consider authorizing reverse share splits at an aggregate ratio of 1-for-2 to 1-for-20 within 12 months of the meeting.




